宜通世纪公告，预计2025年归属于上市公司股东的净利润为盈利800万元至1200万元，上年同期为亏损 3034.99万元。业绩变动的主要原因如下：报告期内，尽管公司营业收入较上年同期略有下降，但公司 持续强化成本管控意识，积极落实一系列切实有效的降本增效措施，成功实现毛利率的稳步提升，从而 对整体利润水平产生了积极影响。 ...

| 项 目 | | 本报告期 | 上年同期 | | | --- | --- | --- | --- | --- | | 归属于上市公司 股东的净利润 | 盈利：800.00 | 万元～1,200.00 万元 | 亏损：3,034.99 | 万元 | | 扣除非经常性损 益后的净利润 | 盈利：500.00 | 万元 万元～700.00 | 亏损：7,727.81 | 万元 | 注：本表格中的"万元"均指人民币万元 二、与会计师事务所沟通情况 本次业绩预告相关的财务数据未经会计师事务所审计。公司已就业绩预告 有关事项与会计师事务所进行了预沟通，双方在本报告期的业绩预告方面不存 在重大分歧。 证券代码：300310 证券简称：宜通世纪 公告编码：2026-001 宜通世纪科技股份有限公司 2025 年年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年12月31日 2、业绩预告情况：预计净利润为正值且属于扭亏为盈情形 三、业绩预告变动原因说明 预计公司 2025 年归属上市公司股东的净 ...

Core Viewpoint - The article discusses the ongoing legal actions regarding investor claims against Yitong Century (宜通世纪), highlighting the company's financial misconduct and the potential for investors to seek compensation through legal channels [1][2][3]. Group 1: Legal Proceedings - On January 13, 2026, the Shanghai Jiucheng Law Firm, represented by lawyer Xu Feng, submitted another case for investor claims against Yitong Century to the Guangzhou Intermediate People's Court [1]. - Some previous investor claims handled by Xu Feng have already reached settlements, and the firm continues to accept new claims from other investors [1][3]. Group 2: Financial Misconduct - On June 21, 2023, Yitong Century received an administrative penalty decision from the China Securities Regulatory Commission (CSRC) due to significant financial misconduct [2][3]. - Between May 1 and December 31, 2017, Yitong Century's subsidiary, Beitai Health, engaged in financial fraud, inflating revenue by 97.34 million yuan, costs by 52.61 million yuan, and total profits by 40.84 million yuan, which represented 3.7%, 9.75%, and 15.67% of the company's reported figures, respectively [2][4]. Group 3: Investor Compensation Eligibility - Investors who purchased Yitong Century shares between April 3, 2018, and November 4, 2022, and sold or continued to hold their shares after November 4, 2022, are eligible to file for compensation based on previous favorable judgments [5].

Group 1 - The core viewpoint of the news is that Yitong Century's stock has shown a positive performance with a 4.01% increase on January 9, 2025, and a trading volume of 717 million yuan [1] - On January 9, 2025, Yitong Century had a financing buy-in amount of 83.73 million yuan, with a net financing buy of 24.96 million yuan, indicating a relatively low financing balance compared to the past year [1] - The total financing and securities balance of Yitong Century reached 355 million yuan, which is 6.22% of its circulating market value, indicating a low level compared to the 40th percentile over the past year [1] Group 2 - Yitong Century Technology Co., Ltd. was established on October 9, 2001, and listed on April 25, 2012, with its main business involving communication network engineering services and solutions [2] - As of September 30, 2025, Yitong Century reported a revenue of 1.694 billion yuan, a year-on-year decrease of 5.04%, and a net profit attributable to shareholders of 3.39 million yuan, down 86.05% year-on-year [2] - The company has distributed a total of 137 million yuan in dividends since its A-share listing, with no dividends distributed in the last three years [3]

证券之星消息，1月6日通信服务板块较上一交易日上涨0.79%，宜通世纪领涨。当日上证指数报收于 4083.67，上涨1.5%。深证成指报收于14022.55，上涨1.4%。通信服务板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300310 | 官通世纪 | 6.53 | 6.18% | 95.45万 | 6.12亿 | | 300211 | *ST亿通 | 9.19 | 5.27% | 6.61万 | 5991.89万 | | 002544 | 普天科技 | 36.34 | 4.10% | 56.16万 | 20.14亿 | | 300383 | 光环新网 | 13.46 | 3.86% | 100.90万 | 13.64亿 | | 300442 | 润泽科技 | 57.63 | 2.93% | 63.71万 | 35.82亿 | | 300738 | 噢飞数据 | 19.60 | 2.56% | 50.37万 | 9.86亿 | | 920924 | 广脉科技 | 21 ...

Market Overview - The Shanghai Composite Index closed at 4083.67 points, above the six-month moving average, with an increase of 1.50% [1] - The total trading volume of A-shares reached 33,301.51 million yuan [1] Stocks Above Six-Month Moving Average - A total of 244 A-shares have surpassed the six-month moving average today [1] - Notable stocks with significant deviation rates include: - Hanxin Technology: 25.26% - Qiangli New Materials: 13.64% - Tianli Technology: 11.68% [1] Stocks with Minor Deviation Rates - Stocks with smaller deviation rates that have just crossed the six-month moving average include: - Future Electric - ST Langyuan - Guojin Securities [1] Top Performing Stocks - The top stocks with the highest deviation rates and their respective performance metrics are: - Hanxin Technology: 29.99% increase, 25.42% turnover rate, latest price 48.89 yuan - Qiangli New Materials: 15.84% increase, 36.12% turnover rate, latest price 15.80 yuan - Tianli Technology: 20.01% increase, 19.26% turnover rate, latest price 32.21 yuan [1] Additional Notable Stocks - Other notable stocks with significant performance include: - Tonghuashun: 12.01% increase, 8.84% turnover rate, latest price 372.00 yuan - Binhu Chemical: 9.95% increase, 5.78% turnover rate, latest price 4.75 yuan - AVIC Xi'an: 10.00% increase, 4.45% turnover rate, latest price 28.48 yuan [1]

Core Viewpoint - The article discusses ongoing legal actions against Yitong Century (300310) due to false statements leading to investor claims, with a focus on recent court rulings and financial misconduct by the company [1][2]. Group 1: Legal Proceedings - Yitong Century is currently facing investor claims related to false statements, with lawsuits filed and ongoing efforts to accept additional claims from investors [1]. - A civil judgment was issued on December 30, 2025, requiring Yitong Century to compensate 109 investors a total of 2,729,003.27 yuan, with certain individuals held jointly liable for the company's debts [1]. - The law firm representing the investors has noted that previous claims have resulted in settlements, and they continue to pursue further cases [1]. Group 2: Financial Misconduct - An investigation revealed that from May 1 to December 31, 2017, Yitong Century's subsidiary, Beitai Health, engaged in financial fraud, inflating revenue by 97.34 million yuan, costs by 52.61 million yuan, and total profits by 40.84 million yuan, which constituted 3.7%, 9.75%, and 15.67% of the company's reported figures, respectively [2]. - This fraudulent activity led to the issuance of an administrative penalty by the China Securities Regulatory Commission on June 21, 2023, highlighting the company's failure to disclose accurate financial information in its annual reports [2]. Group 3: Investor Eligibility for Claims - Investors who purchased Yitong Century shares between April 3, 2018, and November 4, 2022, and sold or held their shares after November 4, 2022, are still eligible to file claims for compensation [3].

Core Viewpoint - The article discusses the ongoing legal actions and compensation claims against Yitong Century (宜通世纪) due to false statements that have led to investor losses, highlighting the potential for further claims by affected investors [1][3][4]. Group 1: Legal Proceedings - Yitong Century has been ordered by the Guangzhou Intermediate People's Court to compensate 109 investors a total of 2,729,003.27 yuan for investment losses, with a deadline of fifteen days from the judgment date for payment [4]. - The law firm Shanghai Jiucheng, represented by lawyer Xu Feng, is actively pursuing compensation claims for investors who purchased Yitong Century shares between April 3, 2018, and November 4, 2022, and either sold or continued to hold the shares after November 4, 2022 [3][5]. Group 2: Regulatory Actions - On June 21, 2023, Yitong Century received an administrative penalty decision from the China Securities Regulatory Commission (CSRC) due to violations related to financial misstatements during a major asset restructuring in October 2016 [2][4]. - The restructuring involved the acquisition of 100% of Shenzhen Beitai Health Measurement Analysis Technology Co., Ltd. for a total consideration of 1 billion yuan, which included issuing 21.7899 million shares and cash payment of 440 million yuan [2][4]. Group 3: Financial Misconduct - From May 1 to December 31, 2017, Beitai Health engaged in financial fraud, inflating revenue by 97.3439 million yuan, costs by 52.6099 million yuan, and total profit by 40.8386 million yuan, which represented 3.7%, 9.75%, and 15.67% of Yitong Century's reported figures, respectively [5].

证券代码：300310 证券简称：宜通世纪 公告编号：2025-051 宜通世纪科技股份有限公司 关于涉及诉讼事项的进展暨收到《民事判决书》的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示: 1.案件所处的诉讼阶段：一审判决 2.上市公司所处的当事人地位：被告 3.涉案的金额：赔偿金额人民币 2,729,003.27 元，案件受理费人民币 26,592.03 元，合计人民币 2,755,595.30 元。 4.对上市公司损益产生的影响：本公告所述的诉讼案件民事判决结果，可以在 规定期限内提起上诉，案件执行结果尚存在不确定性，目前暂无法判断对公司本期 或期后利润的影响。 宜通世纪科技股份有限公司（以下简称"公司"）于 2025 年 12 月 30 日收到广东 省广州市中级人民法院关于原告陈*华、阮*良等 109 名投资者与公司证券虚假陈述 责任纠纷议案的《民事判决书》（2024）粤 01 民初 418 号，现将涉及的诉讼进展事 项公告如下： 一、诉讼事项的基本情况 公司于 2024 年 5 月 29 日收到广东省广州市中级人民法院送达的《民事 ...

（文章来源：证券日报） 证券日报网讯 12月24日，宜通世纪发布公告称，截至本公告披露日，公司担保额度总金额为8，000万 元，占公司最近一期经审计净资产的比例为4.29%；已发生的担保余额为946万元，占公司最近一期经 审计净资产的比例为0.51%。除上述担保外，公司及子公司无其他对外担保，也不存在逾期担保，无涉 及诉讼的担保金额及因担保被判决败诉而应承担损失的情形。 ...